MedTech Association Adds Six New Board Members
Tuesday, November 12, 2019
Source: MedTech Association
MedTech Association, a membership-based trade association for the bioscience and medical technology (Bio/Med) industry in New York State, has added six highly-qualified community and industry leaders to its 2019-2020 board of directors, under the leadership of its board chair, Sarah Oliker of CONMED Corporation. Win Thurlow, MedTech’s executive director, offered his thanks to the 2018-2019 board, noting their many achievements over the year and charged the new board with advancing the organization's mission. For a complete listing of MedTech directors, visit here.
Director of Communications, AngioDynamics
Saleem M. Cheeks was named AngioDynamics’ Director of Communications in February 2018 bringing with him more than 16 years of private and public-sector experience in communications, community relations and politics. Prior to joining AngioDynamics, Mr. Cheeks served as a key member of the Mower public affairs practice, where he advised global corporations and non-profits, and developed award-winning communications strategies for major economic development projects. Mr. Cheeks holds a Bachelor of Arts degree in Political Science from the State University of New York at Oswego.
CPA/Principal, The Bonadio Group
Dave is a principal in the firm’s Commercial division. Dave works closely with a wide array of clients including manufacturers, high tech companies, service providers, software companies, private equity firms, contractors, real estate/property management companies, and employee benefit plans. Dave received both his B.S. degree in Accounting and his M.B.A. from St. Bonaventure University. He is a member of the American Institute of Certified Public Accountants.
Head of Association Relations, MasterControl
Theresa Gubler is a diversified communications professional with more than 25 years of experience in strategic marketing, community outreach, association relations, and media relations activities. She has created and managed both national consumer (B2C) and B2B communication programs - building brands with both in-house marketing teams and top ad/PR agencies, and for both public (Electronic Arts, Microsoft) and private companies and non-profits. In recent years, Gubler has built in-depth knowledge of the life sciences industry and life sciences manufacturing. Currently, as Head of Association Relations at MasterControl, she partners with state, national and international industry organizations to address quality, regulation and compliance issues.
Director of Strategic Marketing, Hillrom
Dave Rider is the Director of Strategic Marketing for Hillrom. He has a passion for identifying new solutions, building business cases and working cross-functionally to accelerate market adoption. In his current role, he is responsible for defining, driving and bringing to market differentiated healthcare solutions both through organic and inorganic means. Prior to Hillrom, Dave spent 10 years in research and consulting services focused on portfolio optimization and customer experience for fortune 50 technology and telecommunication companies. He has a bachelor’s in Marketing Management from SUNY Brockport and an MBA from Clarkson University.
Associate Provost for Research & Economic Development, Alfred University
Dr. John J. Simmins is Associate Provost for Research and Economic Development at Alfred University. In this position, he oversees approximately 50 research faculty and 200 graduate students. In addition, he directs the efforts of the NYS Center for Advanced Ceramic Technology (CACT) as Executive Director. Simmins is also partially responsible for bringing jobs and opportunities to western NY and in particular Allegany County, one of the most underserved counties in NY State.
Director of Regulatory Science Programs, Clinical & Translational Science Institute, University of Rochester Medical Center
Scott Steele is the Director of Regulatory Science Programs in the Clinical and Translational Science Institute at the University of Rochester Medical Center. In this role he develops and leads regulatory science and translational science programs, including serving as Program Director for a Certificate in Regulatory Science. He is an associate professor in the Department of Public Health Sciences, where his academic interests are focused on a range of science and technology policy issues, including regulatory science, public health preparedness, and national security. Dr. Steele also serves as the Director of Government and Academic Research Alliances at the University of Rochester, where he facilitates strategic research and educational partnerships between the University and government agencies and laboratories, and other academic institutions. He completed his MA and PhD in Molecular Biology at Princeton University.